Powder: -20°C for 3 years | In solvent: -80°C for 1 year
STING agonist-3 is a selective and non-nucleotide small-molecule STING agonist(pEC50 and pIC50 of 7.5 and 9.5, respectively), has durable anti-tumor effect and tremendous potential to improve treatment of cancer.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
500 μg | ¥ 1,080 | 35日内发货 | ||
1 mg | ¥ 1,970 | 35日内发货 | ||
5 mg | ¥ 8,340 | 35日内发货 | ||
10 mg | ¥ 14,500 | 35日内发货 |
产品描述 | STING agonist-3 is a selective and non-nucleotide small-molecule STING agonist(pEC50 and pIC50 of 7.5 and 9.5, respectively), has durable anti-tumor effect and tremendous potential to improve treatment of cancer. |
体外活性 | STING agonist-3 exhibits activation of STING in cells(pEC50 of 7.5), this assay is determined using a luciferase reporter assay in human embryonic kidney cells (HEK293T) co-transfected with plasmids expressing STING and the enzyme firefly luciferase driven by the interferon stimulated response element promoter.In FRET assay, STING agonist-3 exhibits a pIC50 value of 9.5 . This is a competition binding assay which aims to determine the binding potency of molecules to the C-terminal Domain (CTD) of human STING. |
分子量 | 750.81 |
分子式 | C37H42N12O6 |
CAS No. | 2138299-29-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (166.49 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.3319 mL | 6.6595 mL | 13.3189 mL | 33.2974 mL |
5 mM | 0.2664 mL | 1.3319 mL | 2.6638 mL | 6.6595 mL | |
10 mM | 0.1332 mL | 0.6659 mL | 1.3319 mL | 3.3297 mL | |
20 mM | 0.0666 mL | 0.333 mL | 0.6659 mL | 1.6649 mL | |
50 mM | 0.0266 mL | 0.1332 mL | 0.2664 mL | 0.6659 mL | |
100 mM | 0.0133 mL | 0.0666 mL | 0.1332 mL | 0.333 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
STING agonist-3 2138299-29-1 Others STING agonist 3 STING agonist3 Inhibitor inhibitor inhibit